9 employees
Zura Bio is a clinical-stage biotechnology company that develops medicines for immune system disorders.
2022
$80M
from 2 investors over 2 rounds
Zura Bio Limited raised $80M on April 27, 2023
Investors: Suvretta Capital Management LLC and Great Point Partners